Please assess the completion status of the following clinical trial:

Trial Title: Identifying Pain Generators and Potentiators of Residual Complaints Following Lumbar Discectomy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Dutch speaking~* Body mass index below 35kg/m²~* Lumbar radiculopathy patients, classified as ASA I to II without any symptoms of spinal cord compression (i.e. bilateral leg pain), who are scheduled for a first-time, single-level, unilateral lumbar discectomy~* Healthy, pain-free controls (score 0 on a visual analogue scale from 0 to 100)~Exclusion Criteria:~* Female participants will be excluded if pregnant, lactating or \<1 year postnatal~* Having (a history) of severe medical disorders either respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurologic (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), endocrinological (e.g. diabetes), psychiatric (e.g. post-traumatic stress disorder~* Having a history of spinal surgery (e.g. discectomy), spinal traumata (e.g. vertebral fracture) or severe spinal deformities (e.g. spondylolisthesis)~* Having a pacemaker or defibrillator~* Healthy controls will be excluded if having suffered low back pain in the preceding year of score 2 or higher on the visual analog scale and which limited their activities of daily living or for which they consulted a (para)medic.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Lumbar radiculopathy (Type: None): Lumbar radiculopathy patients (n=122), classified as ASA I to II without any symptoms of spinal cord compression (i.e. bilateral leg pain), who are scheduled for a first-time, single-level, unilateral lumbar discectomy.
- Healthy controls (Type: None): Sex, age, and BMI-matched healthy, pain-free control subjects (n=122) will be recruited for study participation.

Based on this trial design, predict the completion outcome and termination type (if applicable).